Alios BioPharma Presented Data on Its First-in-Class Anti-Respiratory Syncytial Virus (RSV) Nucleoside Analogs at the 8th Annual Respiratory Syncytial Virus Symposium
10/1/2012 10:07:39 AM
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Vows to Fight on With Alios BioPharma Drugs in High-Stakes Hepatitis C Race
1/24/2012 7:24:04 AM
More...
|
Vertex Pharmaceuticals (MA) (VRTX) and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C
12/9/2011 6:51:43 AM
More...
|
Alios BioPharma Signs Flu Treatment Deal with University of Hong Kong
10/31/2011 2:08:32 PM
More...
|
U.S. Biotech Alios BioPharma and Versitech Ltd. Announce Exclusive Worldwide Licensing Agreement for Influenza Technology
10/31/2011 8:32:30 AM
More...
|
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline
6/13/2011 7:59:34 AM
More...
|
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer
2/7/2011 8:31:04 AM
More...
|
Alios BioPharma Issued Broad U.S. Patent for Glyco-Engineered Interferons
10/16/2009 8:39:33 AM
More...
|
Biotech Industry Veteran K. Peter Hirth Joins Alios BioPharma Board of Directors
8/13/2009 1:45:48 PM
More...
|
Alios BioPharma Closes $32 Million Series A Financing
6/11/2009 7:35:14 AM
More...
|
|